Federal Funding Opportunities for Life Sciences

Life sciences innovators are at the forefront of global health advancement, from next-generation therapeutics and diagnostics to biosecurity, medical devices, and precision medicine. With increasing federal investment across biotechnology, public health, and national preparedness, EverGlade partners with companies pursuing federal funding for transformative innovations, helping teams navigate funding strategy, design compelling proposals, streamline negotiations, and successful post-award execution.

The Life Sciences Federal Funding Landscape

Federal R&D agencies like ARPA-H, BARDA, and DARPA invest billions annually in biotechnology, therapeutics, diagnostics, vaccines, and health security innovation.

Successfully navigating this landscape requires more than scientific and technical expertise alone. Companies must align their technologies with evolving agency priorities, financial and compliance requirements, and mission-driven program objectives.

From early-stage strategy through proposal submission and post-award execution, we help innovators navigate the complexities of U.S. Government funding with strategic, technical, financial, compliance, and operational expertise built for highly regulated environments.

Federal Agencies Driving Life Sciences Innovation

Each federal agency operates with distinct missions, funding mechanisms, and focus areas. Understanding how these organizations evaluate innovation is critical to pursuing, negotiating, and executing federally funded programs.

ARPA-H

Advanced Research Projects Agency for Health

Advancing transformative health technologies and capabilities through high-impact programs designed to accelerate breakthroughs beyond traditional research or commercial models.

BARDA

Biomedical Advanced Research and Development Authority

Accelerating research and development of medical countermeasures that strengthen public health and national preparedness.

DARPA

Defense Advanced Research Projects Agency

Driving transformational breakthroughs that advance national security, defense capabilities, and next-generation technology innovation.

CPE CBRND

Capability Program Executive Chemical, Biological, Radiological and Nuclear Defense

Strengthening chemical, biological, radiological, and nuclear defense capabilities through advanced warfighter technologies, defense equipment, and medical countermeasures.

NIAID (NIH)

National Institute of Allergy and Infectious Diseases (National Institutes of Health)

Supporting infectious disease, biodefense, vaccine, therapeutics, and public health innovation that advances healthcare technologies and national preparedness, under the NIH.

Why EverGlade?

Federal funding is our science. We create, support, and manage strategic partnerships between innovators and funding agencies to maximize the impact of investment dollars while accelerating our clients’ growth.

Proven in Highly Regulated Federal Environments

With over 50 programs actively managed, we bring hands-on experience across federal agencies in a number of industries, navigating the strategic, technical, and regulatory demands that define successful programs.

Technical & Regulatory Fluency That Drives Post-Award Success

We are PhD-level scientists, former U.S. Government COTRs and SETAs, and federal procurement, financial, cost accounting & compliance regulatory experts who bring diverse perspectives to every stage of the funding lifecycle.

Successful Transition from Program Design to Execution

We operate as an extension of your team — like a “think tank” — where the diverse skill sets of our experts help ensure your program is built to perform from day one.

Powered by Proprietary Program Infrastructure

Your team gains access to proprietary intellectual property developed across years of complex R&D and financial program execution, including standardized tools, templates, and processes.

Pursuing or Navigating Federal Funding?

Whether you’re developing your funding strategy, evaluating opportunities, preparing a proposal, or managing a post-award program, EverGlade provides the strategic, technical, financial, compliance, and operational expertise needed to move complex, high-impact programs forward.

Life Sciences FAQ

Which federal agencies fund life sciences and biotech companies?

The main sources of non-dilutive life sciences funding are ARPA-H, BARDA, NIH institutes such as NIAID, DARPA's Biological Technologies Office, and DoD medical programs, each funding a different technology readiness stage. The right target depends on where a technology sits in its development lifecycle. EverGlade maps innovations to the agencies and programs most likely to fund them.

What is non-dilutive funding for biotech companies?

Non-dilutive funding is capital, including grants, contracts, and Other Transaction Agreements (OTAs), that advances R&D without requiring companies to give up equity. It can carry a biotech program through critical milestones while strengthening its position for later private investment. EverGlade helps companies build a non-dilutive funding strategy across ARPA-H, BARDA, NIH/NIAID, and DARPA.

Does the U.S. government fund biomanufacturing?

Yes, biomanufacturing and domestic production capacity are active federal priorities, with BARDA funding smart and on-demand manufacturing, ARPA-H targeting cell-therapy manufacturing, and DoD funding biologics for defense readiness. These awards typically require demonstrated scale-up capability. EverGlade helps life sciences companies position their manufacturing capabilities to compete for them.